Literature DB >> 26053703

Muscle biopsy and UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene mutation analysis in two Chinese patients with distal myopathy with rimmed vacuoles.

Nan Liu1, Zhong-Kun Wang, Hai-Xia Wang, Yan Li, Zhen-Hua Niu, Xue-Fan Yu.   

Abstract

Distal myopathy with rimmed vacuoles is an autosomal recessive genetic disease characterized by weakness of the anterior compartment of the lower limbs, sparing the quadriceps muscle, and rimmed vacuoles in muscle biopsies. The disease is caused by a mutation in the UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE) gene located on chromosome 9p13.3. We present two cases of Chinese patients with progressive lower extremity weakness. Clinical presentation, laboratory evaluation, electrodiagnostic testing, muscle pathology, and genetic analysis are described. Patient 1 was found to have heterozygous missense mutations (p.C13S and p.G576R) in the GNE gene and patient 2 had a homozygous missense mutation (p.C13S). The mutation p.C13S has been reported previously in China, Japan, and South Korea; however, the mutation p.G576R has not been described previously.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26053703     DOI: 10.1097/WNR.0000000000000396

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  3 in total

1.  Distal myopathy with rimmed vacuoles: Spectrum of GNE gene mutations in seven Chinese patients.

Authors:  Feifei Su; Jing Miao; Xuemei Liu; Xiaojing Wei; Xuefan Yu
Journal:  Exp Ther Med       Date:  2018-06-22       Impact factor: 2.447

2.  Clinical, genetic, and pathological characterization of GNE myopathy in China.

Authors:  Xiao-Qing Lv; Ling Xu; Peng-Fei Lin; Chuan-Zhu Yan
Journal:  Neurol Sci       Date:  2022-02-09       Impact factor: 3.307

3.  Identification of a GNE homozygous mutation in a Han-Chinese family with GNE myopathy.

Authors:  Yuan Wu; Lamei Yuan; Yi Guo; Anjie Lu; Wen Zheng; Hongbo Xu; Yan Yang; Pengzhi Hu; Shaojuan Gu; Bingqi Wang; Hao Deng
Journal:  J Cell Mol Med       Date:  2018-08-29       Impact factor: 5.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.